Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Shares of Waters Corp. WAT advanced 2.06% to $287.46 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider Becton Dickinson in a stock-and-cash transaction valued at $17.5 billion, ...

Waters Corp. is paying $17.5B to merger with the biosciences unit of BD, doubling addressable market to $40B. However, ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Waters Corp. reported strong growth rates for FY21 and is expecting solid growth for FY22. See why I think WAT stock is not a good investment right now.

Waters Corporation beat analysts’ revenue expectations by 3.9% last quarter, reporting revenues of $740.3 million, up 4% year on year. It was a very strong quarter for the company, ...

Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments.

Scientific instruments company Waters Corporation (NYSE:WAT) will be reporting earnings tomorrow morning. Here’s what to look for. Waters Corporation beat analysts’ revenue expectations by 1.9 ...

Shares of Waters Corp. WAT slid 0.21% to $267.48 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.14% to 4,191.98 and Dow ...